-- HealthDay staff
MONDAY, April 29 (HealthDay News) -- Danish scientists testing a
novel HIV treatment in human trials contend that they're confident
their strategy will result in a cure for the AIDS-causing virus,
according to news reports.
The technique -- already tested successfully in lab experiments
-- involves freeing the HIV virus from DNA cells, where it collects
in "reservoirs," and bringing it to the surface of the cells, the
Telegraphin Great Britain reported. Once the virus has
surfaced, it can be permanently destroyed by a "vaccine" that
primes the body's natural immune system, the researchers said.
"I am almost certain that we will be successful in releasing the reservoirs of HIV," said Dr. Ole Sogaard, a senior researcher at the Aarhus University Hospital in Denmark, according to the news report. So far the clinical trials are "promising," he said.
Human clinical trials are under way, said Sogaard, adding that
early signs are "promising. I am almost certain that we will be
successful in releasing the reservoirs of HIV," he said.
Fifteen patients are currently taking part in the trials, and if
they are found to have successfully been cured of HIV, the "cure"
will be tested on a wider scale, the
"The challenge will be getting the patients' immune system to recognize the virus and destroy it. This depends on the strength and sensitivity of individual immune systems," Sogaard said, the newspaper reported.
Sogaard said a "cure" is different than a preventative vaccine.
That means continued awareness of unsafe behaviors -- such as
avoiding unprotected sex or sharing needles for intravenous drug
use -- is still the key to combating HIV.
If the Danish researchers are successful, it would obviously
represent a huge step in the battle against HIV.
A large study of an experimental HIV vaccine was halted recently
because the shots weren't preventing infection, the U.S. National
Institutes of Health said last week.
The clinical trial included about 2,500 people, mostly gay men,
in 19 cities. Half of the participants were given the vaccine
developed by the NIH and half received placebo shots. A safety
review found that slightly more people who had received the vaccine
later became infected with HIV. The reasons for this aren't
While the vaccinations are being stopped, the NIH said it will
continue to track the study participants' health, the
Numerous attempts to develop an HIV/AIDS vaccine have
To learn more about HIV, visit the
U.S. National Library of Medicine.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.